| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.5 | 0.001 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |